US equities
|
NVDA
$241.53
▲+1.10%
SPCX
$173.72
▲+1.54%
MU
$1,065.98
▲+0.19%
AMD
$655.24
▲+3.72%
MRVL
$281.09
▲+3.63%
SNDK
$1,672.92
▼-1.83%
AVGO
$378.65
▲+4.45%
INTC
$113.25
▼-2.53%
NVDA
$241.53
▲+1.10%
SPCX
$173.72
▲+1.54%
MU
$1,065.98
▲+0.19%
AMD
$655.24
▲+3.72%
MRVL
$281.09
▲+3.63%
SNDK
$1,672.92
▼-1.83%
AVGO
$378.65
▲+4.45%
INTC
$113.25
▼-2.53%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about Mindbloom
Recent news which mentions Mindbloom
EXCLUSIVE: Mindbloom's Mastermind Series, A Psychedelic Therapy Program For Heartbreak, Burnout & Parallel Challenges
November 29, 2023
Tags
Management
Dylan Beynon
Exclusives
From
Benzinga
Here Are The Latest Psychedelics Partnerships From Production & Supply Chain To Community Action
January 21, 2023
Tickers
AMZN
CLABF
OPTHF
TRUFF
Tags
Penny Stocks
Canadian Controlled Drugs And Substances Act
Ketamine Therapy
From
Benzinga
At-Home Ketamine For Depression: New Study Adds Proof On Its Safety And Efficacy
July 19, 2022
Tags
Markets
At/Home Therapy
Rumors
From
Benzinga